Related Experiment Video
Updated: Jun 2, 2026
07:44
A Porcine Model of Acute Autologous Pulmonary Embolism
Published on: September 6, 2024
Saddle pulmonary thromboembolism with zero Wells' score.
Rajasree Pai Ramachandra Pai1, Raghesh Varot Kangath, Thomas A Brown
1University of Connecticut Health Center, Farmington, USA. rramachandrapai@resident.uchc.edu
Connecticut Medicine
|April 12, 2011
Summary
Venous thromboembolism (VTE), including deep vein thrombosis and pulmonary embolism, affected 117 per 100,000 individuals annually. Early diagnosis and treatment of VTE are crucial for reducing patient mortality and morbidity.
Area of Science:
- Cardiovascular Medicine
- Epidemiology
- Hematology
Background:
- Deep vein thrombosis (DVT) and pulmonary embolism (PE) are significant causes of morbidity and mortality.
- Understanding the incidence and risk factors of venous thromboembolism (VTE) is crucial for public health.
- Previous studies have highlighted the importance of early diagnosis and treatment for VTE.
Observation:
- A retrospective cohort study analyzed 2,218 patients diagnosed with DVT or PE between 1966 and 1990.
- The study observed an annual incidence rate of VTE at 117 per 100,000 population.
- Higher VTE incidence rates were noted in males compared to females (130 vs. 110 per 100,000, respectively), even after age adjustment.
Findings:
- The annual incidence of VTE was 117 per 100,000, with DVT at 48 per 100,000 and PE at 69 per 100,000.
- Males exhibited higher VTE rates than females (130 vs. 110 per 100,000) after age adjustment.
- Identified risk factors for VTE include altered blood flow, hypercoagulability (e.g., Factor V Leiden mutation), and vessel wall abnormalities.
Implications:
- Prompt diagnosis and effective treatment of DVT and PE can substantially decrease mortality and morbidity.
- Recognizing risk factors such as obesity, surgery, pregnancy, and genetic mutations aids in VTE prevention strategies.
- While 80% of DVTs resolve spontaneously, the potential for pulmonary embolism necessitates vigilant management.
Related Concept Videos
01:29Pulmonary Embolism I: Introduction
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
01:19Pulmonary Embolism I: Introduction
A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
01:27Pulmonary Embolism III: Nursing Management
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
01:27Assessment of the Cardiovascular System III: Palpation
Palpation involves feeling the body to evaluate texture, size, consistency, and tenderness for assessing cardiovascular health. The following steps are organized in a head-to-toe order:
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above the...
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above the...